CYTOCHROME P-450 ARACHIDONIC ACID METABOLISM & REGULATION OF RENAL ION TRANSPORT
CYTOCHROME P-450 ARACHIDONIC ACID METABOLISM & REGULATION OF RENAL ION TRANSPORT
批准号:
6270655
负责人:
Matthew Douglas Breyer
金额:
$5.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-01 至 1998-11-30
关键词:
cyclic AMP cytochrome P450 dietary sodium eicosanoid metabolism female human subject hypertension ion transport kidney function laboratory rabbit laboratory rat microelectrodes microsomes pregnancy pregnancy toxemia /hypertension prostaglandin endoperoxide synthase prostaglandin inhibitors prostaglandin receptor renal tubule tissue /cell culture voltage /patch clamp
中文摘要
点击翻译按钮获取中文摘要
英文摘要
It is now clear that certain arachidonate metabolites that derive from
cytochrome P-450 (CP-450) metabolism have important effects on ion and
water transport in the mammalian kidney. What is currently less clear
is the physiologic and pathophysiologic importance of this pathway in
regulating the kidney's contribution to salt and water balance. There
are, however, a number of compelling observations which call for a
thorough analysis of the functional significance of CP-450 arachidonate
metabolism in the regulation of sodium reabsorption by the kidney. These
observations are basically from models of experimental hypertension. In
the spontaneously hypertensive rat (SHR), McGiff, Schwartzman, Abraham
and their colleagues have implicated a role for omega and omega-1
hydroxylation of arachidonic acid in the development of hypertension.
The functional link, however, remains unclear. In studies from our
group, it appears that dietary salt loading markedly induces epoxygenase
activity in the normal rat, but not in the Dahl salt-sensitive genetic
strain of rat. Again, the functional link in the Dahl salt-sensitive
animal has not been elucidated. Although data in hypertensive animal
models provide a major impetus for studying the regulation of sodium
transport by cytochrome P-450 metabolites, we are confident that these
compounds will play an important role in the normal handling of sodium
by the nephron. This project proposes four specific aims: (1) to
identify and characterize the mechanism of action and functional
significance of both CP-450 arachidonate metabolites that augment renal
sodium retention and those metabolites that inhibit renal sodium
reabsorption; (2) to test the hypothesis that cross-metabolism, i.e.,
metabolism of arachidonate by both the CP-450 pathway and the
cyclooxygenase pathway, yields important biologically active metabolites
which modify sodium transport by activating specific prostaglandin
receptor sub-types; (3) to test the hypothesis that the proximal tubule
and collecting duct serve as important sites for arachidonate cross-
metabolism within the kidney; (4) to characterize the urinary excretion
of CP-450 arachidonate metabolites in normal humans, normal humans on
varying salt intake, patients with essential hypertension, and pregnant
females with and without pregnancy-induced hypertension. These studies,
in concert with the multi-discipline approach in this Program Project
Grant, will define the importance of cytochrome P-450 arachidonate
metabolism in the regulation of normal renal function and in alterations
of renal function, that produce or result from hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PPARs in CYP450 Dependent Regulation of Kidney Function
-
批准号:7459642
-
项目类别:
-
资助金额:$13.41万
-
财政年份:2007
-
负责人:Matthew Douglas Breyer
-
依托单位:
Cyclooxygenase Stimulated Neovascularization in Diabetic
-
批准号:7125564
-
项目类别:
-
资助金额:$29.89万
-
财政年份:2005
-
负责人:Matthew Douglas Breyer
-
依托单位:
Cyclooxygenase Stimulated Neovascularization in Diabetic
-
批准号:7043948
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2005
-
负责人:Matthew Douglas Breyer
-
依托单位:
PPARs in CYP450 Dependent Regulation of Kidney Function
-
批准号:6813192
-
项目类别:
-
资助金额:$12.28万
-
财政年份:2004
-
负责人:Matthew Douglas Breyer
-
依托单位:
Generating Mouse Mutants with Diabetic Nephropathy
-
批准号:6524683
-
项目类别:
-
资助金额:$73.53万
-
财政年份:2001
-
负责人:Matthew Douglas Breyer
-
依托单位:
Generating Mouse Mutants with Diabetic Nephropathy
-
批准号:6941309
-
项目类别:
-
资助金额:$97.06万
-
财政年份:2001
-
负责人:Matthew Douglas Breyer
-
依托单位:
Generating Mouse Mutants with Diabetic Nephropathy
-
批准号:6442192
-
项目类别:
-
资助金额:$73.53万
-
财政年份:2001
-
负责人:Matthew Douglas Breyer
-
依托单位:
CYTOCHROME P-450 ARACHIDONIC ACID METABOLISM & REGULATION OF RENAL ION TRANSPORT
-
批准号:6564251
-
项目类别:
-
资助金额:$16.26万
-
财政年份:2001
-
负责人:Matthew Douglas Breyer
-
依托单位:
Generating Mouse Mutants with Diabetic Nephropathy
-
批准号:6654901
-
项目类别:
-
资助金额:$73.53万
-
财政年份:2001
-
负责人:Matthew Douglas Breyer
-
依托单位:
Generating Mouse Mutants with Diabetic Nephropathy
-
批准号:6796361
-
项目类别:
-
资助金额:$84.53万
-
财政年份:2001
-
负责人:Matthew Douglas Breyer
-
依托单位:
Generating Mouse Mutants with Diabetic Nephropathy
-
批准号:6663477
-
项目类别:
-
资助金额:$12.38万
-
财政年份:2001
-
负责人:Matthew Douglas Breyer
-
依托单位:
Generating Mouse Mutants with Diabetic Nephropathy
-
批准号:7151017
-
项目类别:
-
资助金额:$28.7万
-
财政年份:2001
-
负责人:Matthew Douglas Breyer
-
依托单位:
MEDULLARY CYCLOOXYGENASE PRODUCTS AND RENAL DISEASE
-
批准号:6499585
-
项目类别:
-
资助金额:$13.53万
-
财政年份:2001
-
负责人:Matthew Douglas Breyer
-
依托单位:
Generating Mouse Mutants with Diabetic Nephropathy
-
批准号:6863244
-
项目类别:
-
资助金额:$11.0万
-
财政年份:2001
-
负责人:Matthew Douglas Breyer
-
依托单位:
Generating Mouse Mutants with Diabetic Nephropathy
-
批准号:6954619
-
项目类别:
-
资助金额:$13.45万
-
财政年份:2001
-
负责人:Matthew Douglas Breyer
-
依托单位:
MEDULLARY CYCLOOXYGENASE PRODUCTS AND RENAL DISEASE
-
批准号:6338756
-
项目类别:
-
资助金额:$8.41万
-
财政年份:2000
-
负责人:Matthew Douglas Breyer
-
依托单位:
CYTOCHROME P-450 ARACHIDONIC ACID METABOLISM & REGULATION OF RENAL ION TRANSPORT
-
批准号:6412921
-
项目类别:
-
资助金额:$16.26万
-
财政年份:2000
-
负责人:Matthew Douglas Breyer
-
依托单位:
COX2 EXPRESSION IN GENITOURINARY CANCER AND DEVELOPMENT
-
批准号:6381983
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2000
-
负责人:Matthew Douglas Breyer
-
依托单位:
COX2 EXPRESSION IN GENITOURINARY CANCER AND DEVELOPMENT
-
批准号:6310781
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2000
-
负责人:Matthew Douglas Breyer
-
依托单位:
MEDULLARY CYCLOOXYGENASE PRODUCTS AND RENAL DISEASE
-
批准号:6201864
-
项目类别:
-
资助金额:$8.41万
-
财政年份:1999
-
负责人:Matthew Douglas Breyer
-
依托单位:
海外基金